Lab-Developed Tests: FDA Gives Extra Time For Input On Oversight Plan
This article was originally published in The Gray Sheet
FDA plans to accept feedback through Sept. 15 on its ongoing efforts to develop a regulatory framework for tests developed and offered as services by clinical laboratories
You may also be interested in...
FDA says it will tailor its future oversight of laboratory tests and services based on risk, but experts warn that "high risk" will be hard to define for these diagnostics
FDA could have a final framework in place for overseeing a greatly expanded range of laboratory test services within months of a public meeting scheduled for July, according to agency officials
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.